Kinnevik AB (publ)
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed January 23, 2025), Kinnevik AB (publ) reported 1 stock position worth $80.5 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 100.0% of the portfolio. Its holdings were unchanged from Q3 2024.
- Most Recent 13F
- Q3 2025
- Location
- STOCKHOLM, V7
- CIK
- 0001766574
- Portfolio Value
- $80.5M (Q4 2024)
- SEC Filing
- 0001104659-25-005615 ↗ filed Jan 23, 2025
Holdings Value
Holdings 1 stocks · $80.5M
| RXRX Recursion Pharmaceuticals-A | 100.00% | 11,905,668 | $80.5M | No change |
Portfolio Sells Q3 2024 → Q4 2024
| None this quarter. | |||
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||